Feed CRESY
CR

Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria CRESY NASDAQ · Industrials · Argentina

$7.79 -2.81% -$0.23

Summary

53 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 25% a year over the last 3 years.
  • The share price is below the Bulios Fair Price.

What to watch

  • Repaying its net debt would take 4.9 years of operating profit.
  • It pays out more in dividends than it earns: 115% of profit.
  • It reports a profit, yet spends more cash than it brings in.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $7.79

By our assumptions the business is worth more than its shares cost today.

P/E today 6.7 26% higher
5-year average P/E 5.3
P/E today 6.7
Conglomerates industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 6.7 ARS for 1 ARS of yearly profit. Over the last five years it was 5.3 ARS on average.

Valuation in detail

Is it growing?

Slowly

Revenue (ARS)

Diluted EPS (ARS)

  • Analyst estimate

Revenue grew by 56% a year over 5 years. Over the last 3 years it grew by 25% a year.

Growth in detail

Does it make money?

Reasonably

Where 100 ARS of revenue goes

Net profit, industry median (Conglomerates) 6.2 ARS

Out of every 100 ARS of revenue, 9.6 ARS is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
17.21%
Paid out of profit
115%

You receive $0.75 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $12.68 is 63% above today's price. 100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2024

By product

The company reports no revenue by product.

By region

Other Countries brings in 50% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy